The Patent Finder
AI

Allergan Industrie SAS

First filing 2008
OverviewNotableFeesChangesFamiliesPatent listSources & methods

38 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Dec 2028. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
24
Ending by 2030
Dec 2028
Next term end
10
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Hyaluronic Acid-Based Gels Including Lidocaine US 8,450,475
The most cited patent in this portfolio, cited by 125 later US patents, top 5% of utility patents granted in 2013 in our data. Protection runs to 2030.
Ends Dec 2030 · High confidence
Also notable
Polysaccharide Gel Formulation Having Increased Longevity US 8,394,782
Cited by 122 later US patents, top 5% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028. A terminal disclaimer caps this term to an earlier patent's.
Ends Dec 2028 · Medium confidence
Also notable
Dermal Filler Compositions US 11,083,684
Cited by 17 later US patents, top 10% of utility patents granted in 2021 in our data. Protection runs to 2032.
Ends Jun 2032 · Medium confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 3 fees due Jan 28, 2027
  • 2 fees due Feb 25 to 27, 2027 · next Feb 25
  • 2 fees due Apr 6 to 22, 2027 · next Apr 6
  • 1 fee due May 26, 2027
    The maintenance fee for Hyaluronic Acid-Based Gels Including Lidocaine (US 10,485,896) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
  • 1 fee due Jul 19, 2027
    The maintenance fee for Hyaluronic Acid-Based Gels Including Lidocaine (US 9,238,013) comes due Jul 19, 2027. Unpaid by Jan 19, 2028, it lapses early.
  • 1 fee due Sep 24, 2027
    The maintenance fee for Thread Insertion Devices (US 10,595,977) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
  • 1 fee due Oct 21, 2027
    The maintenance fee for Dermal Filler Compositions Including Antioxidants (US 10,624,988) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
  • 1 fee due Nov 10, 2027
    The maintenance fee for Heat Stable Hyaluronic Acid Compositions for Dermatological Use (US 9,333,160) comes due Nov 10, 2027. Unpaid by May 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 21, 2026

What they patent

The largest of its 10 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,394,782Polysaccharide Gel Formulation Having Increased Longevity
In force
 · Medium confidence
In forceMedium confidence
US 8,822,676Hyaluronic Acid-Based Gels Including Lidocaine
In force
 · High confidence
In forceHigh confidence
US 9,089,517Hyaluronic Acid-Based Gels Including Lidocaine
In force
 · Medium confidence
In forceMedium confidence
US 9,089,518Hyaluronic Acid-Based Gels Including Lidocaine
In force
 · Medium confidence
In forceMedium confidence
US 9,089,519Hyaluronic Acid-Based Gels Including Lidocaine
In force
 · Medium confidence
In forceMedium confidence
US 9,238,013Hyaluronic Acid-Based Gels Including Lidocaine
In force
 · High confidence
In forceHigh confidence
US 10,328,180Hyaluronic Acid-Based Gels Including Lidocaine
In force
 · Low confidence
In forceLow confidence
US 10,391,202Hyaluronic Acid-Based Gels Including Lidocaine
In force
 · Medium confidence
In forceMedium confidence
US 10,485,896Hyaluronic Acid-Based Gels Including Lidocaine
In force
 · Medium confidence
In forceMedium confidence
US 11,020,512Hyaluronic Acid-Based Gels Including Lidocaine
In force
 · Medium confidence
In forceMedium confidence
10 of 38 patents shown.
Pro members see all 38.
Pro members: see all 38 patents
Also on record, not counted in the 38: 9 patents ended · 4 applications pending · 24 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited